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Learning Point for Clinicians
Prinzmetal angina is characterized by recur-
rent angina symptoms at rest and transient
ST-segment changes. Prinzmetal angina can be
a life-threatening condition with complications
reaching from malignant arrhythmia, high
degree AV-block to death. Therefore, prompt rec-
ognition of Prinzmetal angina is essential to avoid
complications and provide appropriate manage-
ment to improve outcome.
Case report
A 67-year-old female patient and former smoker
presented to the emergency room (ER) with severe
onset of chest pain. Admission ECG demonstrated
ST-segment elevation in the inferior leads (Figure
1a). The patient reported to have chest pain the
last couple of days associated with dyspnea. Her
past medical history revealed familial adenomatous
polyposis since 4 years and she has had a whipple
surgery. Furthermore she had polyarthritis and
esophageal spasm. For the latter she had been
taken nitroglycerin if required because she did not
respond to calcium-channel blockers. This time
chest pain was completely different in character
compared to the esophageal spasm that she had
experienced in the past and she had never felt dys-
pnea and dizziness before for which reason she pre-
sented in the ER.
In the ER symptoms spontaneously resolved after
some minutes and ST-segment elevation slightly dis-
appeared in a repeated ECG. The patient was imme-
diately brought to cath lab because of suspicion of
myocardial infarction. Interestingly, emergency cor-
onary angiography imposed narrowing of all epicar-
dial vessels (Figure 1b) while the patient
experienced chest pain and transient ST-segment
elevation. After application of nitroglycerin intraven-
ously impressive vasodilation of all vessels was
observed (Figure 1c). Cardiac enzymes, which
were available after cath, showed troponin, CK
and CK-MB within the normal range. NTpro-BNP
was slightly elevated (317 ng/l). Notably, the patient
had consulted her general practitioner 2 weeks
before her presentation in the emergency depart-
ment, because of dizziness, pre-syncope and chest
pain symptoms. A 24-h Holter-ECG monitoring had
demonstrated intermittent AV-block-III. She was
already scheduled for an appointment for a pace-
maker (PM) implantation, which was then per-
formed, during her current hospitalization.
This clinical picture is consistent with Prinzmetal
angina complicated by AV-block. The patient was
treated with a calcium-channel blocker and nitro-
glycerin was continued. Furthermore fluvastatin
was added due to potential beneficial effects on
endothelial function and reduction of coronary
spasm. Repeated counseling and 1-year follow-up
revealed no more angina symptoms.
! The Author 2013. Published by Oxford University Press on behalf of the Association of Physicians.
All rights reserved. For Permissions, please email: journals.permissions@oup.com
Q J Med 2014; 107:375–377
doi:10.1093/qjmed/hct228 Advance Access Publication 12 November 2013
Discussion
Here we describe a case of Prinzmetal angina com-
plicated by advanced degree AV-block. The first
case of Prinzmetal angina was described in 1959
by Prinzmetal.1 Since then, several trigger factors
have been reported to be associated with
Prinzmetal angina these include, illict drugs such
as cocaine, amphetamine or marijuana, but also
bitter-orange, alcohol, butane, chemotherapy
drugs, over-the-counter medication and different
antibiotics. However, vasospastic angina can also
occur without any triggering factor.2 The classical
symptom is recurrent angina at rest with spontan-
eous remission. A circadian pattern has been
noted and Prinzmetal angina preferentially occurs
in the morning hours. Complications comprise myo-
cardial infarction, malignant arrhythmia and even
sudden cardiac arrest or death. A complete AV-
block can also result in Stokes–Adam-attacks and
patients should be then treated with PM.
Conflicting results exists on the pathophysiology,
proposed mechanisms responsible for this disease
entity are hyperactivity of the sympathetic ner-
vous system and vagal withdrawal or reduced
Figure 1. ECG demonstrated ST-segment elevation in the inferior leads (A), Emergency coronary angiography imposed
narrowing of all epicardial vessels (B) while the patient experienced chest pain and transient ST-segment elevation.
After application of nitroglycerin intravenously vasodilation of all vessels was observed (C).
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nitric oxide synthase and endothelial dysfunction.
While Egashira et al.3 demonstrated enhanced
Phopholipase C enzyme activity resulting in vaso-
spastic angina without impairment of nitric oxide
synthase. A genetic predisposition has also been dis-
cussed.4 Therapeutic management consists of cal-
cium-channel blockers and long-term nitrates with
their vasodilatory effects. Furthermore Fluvastatin
demonstrated a positive effect on endothelial func-
tion and can be therefore recommended.5 In pa-
tients with life-threatening arrhythmia an ICD
should be considered.6
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